Jefferies Group's ABUS Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 1.71 M shares of Arbutus Biopharma Corporation (ABUS) worth $8.22 M, representing 0.05% of the portfolio. First purchased in 2023-Q2, this short-term holding has been held for 5 quarters.
Based on 13F filings, Jefferies Group has maintained this position in ABUS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 1.89 M shares. Largest reduction occurred in Q4 2023, reducing 264,441 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Arbutus Biopharma Corporation (ABUS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Arbutus Biopharma Corporation (ABUS) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -182,395 | Reduce 9.63% | 1.71 M | $4.80 |
| Q1 2026 | +1.89 M | New Buy | 1.89 M | $4.50 |
| Q4 2023 | -264,441 | Sold Out | 0 | $0.00 |
| Q2 2023 | +264,441 | New Buy | 264,441 | $2.30 |
Jefferies Group's Arbutus Biopharma Corporation Investment FAQs
Jefferies Group first purchased Arbutus Biopharma Corporation (ABUS) in Q2 2023, acquiring 264,441 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Arbutus Biopharma Corporation (ABUS) for 5 quarters since Q2 2023.
Jefferies Group's largest addition to Arbutus Biopharma Corporation (ABUS) was in Q1 2026, adding 1,894,067 shares worth $8.52 M.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 1,711,672 shares of Arbutus Biopharma Corporation (ABUS), valued at approximately $8.22 M.
As of the Q2 2026 filing, Arbutus Biopharma Corporation (ABUS) represents approximately 0.05% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Arbutus Biopharma Corporation (ABUS) was 1,894,067 shares, as reported at the end of Q1 2026.